News and Comments

Onyx (ONXX) Was Right All Along

  Monday, July 26, 2010

In October 2009, Onyx (ONXX) paid $276 million up front to acquire the privately held Proteolix to get to its multiple myeloma drug carfilzomib. It promised $535 million in future payments largely contingent on carfilzomib's approval. As usual, investors did not like Onyx paying money, because investors do not like any company to pay money to develop or acquire state-of-the- art products. When somebody hates something he sees everything in it with pessimism. Onyx put its hands on carfilzomib, which looked very promising for multiple myeloma cases resistant to current treatments. The breakthrough multiple myeloma drugs Velcade (bortezomib) and Revlimid (lenolidamide) could not prevent the cancer from recurring and failed to work at all on a large percentage of recurrent cancer.  More...


Recent Postings


Archive


Tags

Agenus (AGEN Multiple Myeloma TOKAI (TKAOI) ADVENTRIX (ANX) Dynavax (DVAX) REGULUS (RGLS) C4 Therapeutics Amgen (AMGN) AstraZeneca (AZN) Mirati Therapeutics (MRTX) Benlysta (belimumab) Revlimid (lenolidamide) Regeneron (REGN) ZALTRAP™ IDERA (IDRA) Genentech Seattle Genetics (SGEN) Array Pharmaceuticals (ARRY) NANTKWEST (NK) JUNO (JUNO) Cytokinetics (CYTK) Onyx (ONXX) Editas (EDIT) ARGOS (ARGS) Merck (MRK) Aimmune Therapeutics (AIMT) Zerenex Global Cell Therapeutics (GBT) Intercept (ICPT) Velcade (bortezomib) BIOMARIN (BMRN) Human Genome Sciences (HGSI) Telaprevir Sequenom (SQNM) Elan (ELN) NEKTAR (NKTR)) Alder Biopharmaceuticals (ALDR) Herceptin Idenix (IDIX) HALOZYME (HALO) Abbott Laboratories (ABT) SUNESIS PHARMACEUTICALS (SNSS) KITE (KITE) Illumina (ILMN) MODERNA CompuGen (CGEN) Rapamune Roche (ROCHE) PTC Therapeutics (PTCT) OSI (OSIP) Spike Therapeutics (ONCE) Valeant Pharmaceuticals International (VRX) Theravance (THRX) Biogen Idec (BIIB) Prolor Biotech (PBTH) Inovio (INO) Incyte (INCY) Tysabri Gilead (GILD) Alnylam (ALNY) Trastuzumab-DM1 ARCA (ABIO) GUARDIAN HEALTH Roche (RHHBY) AERIE PHARMACEUTICALS Agenus (AGEN) SERES THERAPEUTICS (MCRB) Pluristem (PSTI) ISIS (ISIS) KERYX (KERX) Endometrial Cancer NOVOCURE (NVCR) ImmunoGen (IMGN) Human Longevity (HLI) Sarepta (SRPT) SYNTA (SNTA) GlaxoSmithKline (GSK) Theravance Bio Pharma (TBPH) Exelixis (EXEL) INNOVIVA (INVA) Sanofi (SNA) Intrexon (XON) galapagos (GLPG) Vitae Pharmaceuticals (VTAE) Jazz Pharmaceuticals (JAZZ) Ridaforolimus Prosensa (RNA) Sangamo (SGMO) RenenxBio (RGNX) Vertex (VRTX) Dendreon (DNDN) Ionis (IONS) Sanofi-Aventis (SAN) Micromet (MITI) Intermune (ITMN) Galena (GALE) Auspex (ASPX) ACADIA (ACAD) Biocryst (BCRX) Anacor (ANAC) Ziofpharm (ZIOP) Anadys (ANDS) ABBVIE (ABBV) AGOS (ARGS) Ariad (ARIA) Sanofi (SNY) VANDA (VNDA) Xoma (XOMA) Bristol-Myers Squibb (BMY)